175 related articles for article (PubMed ID: 8353246)
1. Visceral leishmaniasis in patients with AIDS: report of three cases treated with pentavalent antimony and interferon-gamma.
de Górgolas M; Castrillo JM; Fernández Guerrero ML
Clin Infect Dis; 1993 Jul; 17(1):56-58. PubMed ID: 8353246
[TBL] [Abstract][Full Text] [Related]
2. Assessment of allopurinol plus meglumine antimoniate in the treatment of visceral leishmaniasis in patients infected with HIV.
Laguna F; López-Vélez R; Soriano V; Montilla P; Alvar J; González-Lahoz JM
J Infect; 1994 May; 28(3):255-9. PubMed ID: 8089514
[TBL] [Abstract][Full Text] [Related]
3. [Acute pancreatitis with a fatal evolution due to antimonials in patients with visceral leishmaniasis and HIV infection].
Santos J; Rivero A; Márquez M
An Med Interna; 2000 Oct; 17(10):562-3. PubMed ID: 11109659
[No Abstract] [Full Text] [Related]
4. Treatment of visceral leishmaniasis in HIV-infected patients: a randomized trial comparing meglumine antimoniate with amphotericin B. Spanish HIV-Leishmania Study Group.
Laguna F; López-Vélez R; Pulido F; Salas A; Torre-Cisneros J; Torres E; Medrano FJ; Sanz J; Picó G; Gómez-Rodrigo J; Pasquau J; Alvar J
AIDS; 1999 Jun; 13(9):1063-9. PubMed ID: 10397536
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of three chemotherapeutic schemes with meglumine antimoniate in the treatment of visceral leishmaniasis in the State of Pará, Brazil.
Marsden PD
Rev Inst Med Trop Sao Paulo; 1993; 35(6):589. PubMed ID: 7997767
[No Abstract] [Full Text] [Related]
6. High frequency of serious side effects from meglumine antimoniate given without an upper limit dose for the treatment of visceral leishmaniasis in human immunodeficiency virus type-1-infected patients.
Delgado J; Macías J; Pineda JA; Corzo JE; González-Moreno MP; de la Rosa R; Sánchez-Quijano A; Leal M; Lissen E
Am J Trop Med Hyg; 1999 Nov; 61(5):766-9. PubMed ID: 10586909
[TBL] [Abstract][Full Text] [Related]
7. A randomized trial comparing a pentavalent antimonial drug and recombinant interferon-gamma in the local treatment of cutaneous leishmaniasis.
Harms G; Chehade AK; Douba M; Roepke M; Mouakeh A; Rosenkaimer F; Bienzle U
Trans R Soc Trop Med Hyg; 1991; 85(2):214-6. PubMed ID: 1909469
[TBL] [Abstract][Full Text] [Related]
8. Low dosage combination of meglumine antimoniate plus allopurinol as first choice treatment of infantile visceral leishmaniasis in Italy.
di Martino L; Mantovani MP; Gradoni L; Gramiccia M; Guandalini S
Trans R Soc Trop Med Hyg; 1990; 84(4):534-5. PubMed ID: 2091347
[No Abstract] [Full Text] [Related]
9. Pharmacokinetic and parasitological evaluation of the bone marrow of dogs with visceral leishmaniasis submitted to multiple dose treatment with liposome-encapsulated meglumine antimoniate.
Schettini DA; Costa Val AP; Souza LF; Demicheli C; Rocha OG; Melo MN; Michalick MS; Frézard F
Braz J Med Biol Res; 2005 Dec; 38(12):1879-83. PubMed ID: 16302103
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of antimony-resistant visceral leishmaniasis with liposomal amphotericin B in patients infected with human immunodeficiency virus.
Torre-Cisneros J; Villanueva JL; Kindelan JM; Jurado R; Sanchez-Guijo P
Clin Infect Dis; 1993 Oct; 17(4):625-7. PubMed ID: 8268341
[TBL] [Abstract][Full Text] [Related]
11. Electrocardiographic findings in Ethiopians on pentavalent antimony therapy for visceral leishmaniasis.
Berhe N; Abraham Y; Hailu A; Ali A; Mengistu G; Tsige K; Abebe Y
East Afr Med J; 2001 Nov; 78(11):608-10. PubMed ID: 12219968
[TBL] [Abstract][Full Text] [Related]
12. Visceral leishmaniasis during pregnancy treated with meglumine antimoniate.
Utili R; Rambaldi A; Tripodi MF; Andreana A
Infection; 1995; 23(3):182-3. PubMed ID: 7499009
[TBL] [Abstract][Full Text] [Related]
13. [Acute pancreatitis due to antimonials in patients with visceral leishmaniasis and HIV infection].
Cortés E; Ribera E; Cucurull E; de Otero J; Ocaña I; Pahissa A
Med Clin (Barc); 1995 Apr; 104(15):578-80. PubMed ID: 7769868
[TBL] [Abstract][Full Text] [Related]
14. Prophylaxis of visceral leishmaniasis in human immunodeficiency virus-infected patients.
Ribera E; Ocaña I; de Otero J; Cortes E; Gasser I; Pahissa A
Am J Med; 1996 May; 100(5):496-501. PubMed ID: 8644760
[TBL] [Abstract][Full Text] [Related]
15. Granulocyte-macrophage colony-stimulating factor in combination with pentavalent antimony for the treatment of visceral Leishmaniasis.
Badaró R; Nascimento C; Carvalho JS; Badaró F; Russo D; Ho JL; Reed SG; Johnson WD; Jones TC
Eur J Clin Microbiol Infect Dis; 1994; 13 Suppl 2():S23-8. PubMed ID: 7875148
[TBL] [Abstract][Full Text] [Related]
16. [A 34-year-old man with lingual tumor. Lingual leishmaniasis in a patient with HIV infection].
Sacristán O; Porcel JM; Panadés MJ; Rubio M
Rev Clin Esp; 2001 Feb; 201(2):103-5. PubMed ID: 11345598
[No Abstract] [Full Text] [Related]
17. Visceral leishmaniasis in HIV-1-infected individuals: a common opportunistic infection in Spain?
Medrano FJ; Hernández-Quero J; Jiménez E; Pineda JA; Rivero A; Sánchez-Quijano A; Velez ID; Viciana P; Castillo R; Reyes MJ
AIDS; 1992 Dec; 6(12):1499-503. PubMed ID: 1362880
[TBL] [Abstract][Full Text] [Related]
18. Antimony/interferon-gamma combination in the treatment of visceral leishmaniasis in AIDS.
Kaplanski G; Buscaylet S; Penot-Ragon C; Durand JM; Soubeyrand J
AIDS; 1996 Sep; 10(10):1172-4. PubMed ID: 8874638
[No Abstract] [Full Text] [Related]
19. Atypical disseminated leishmaniasis resembling post-kala-azar dermal leishmaniasis in an HIV-infected patient.
Boumis E; Chinello P; Della Rocca C; Paglia MG; Proietti MF; Petrosillo N
Int J STD AIDS; 2006 May; 17(5):351-3. PubMed ID: 16643688
[TBL] [Abstract][Full Text] [Related]
20. Treatment of visceral leishmaniasis in a patient with AIDS with antimony and gamma-interferon: remission and prevention of relapse by maintenance therapy with weekly pentamidine.
Lustig V; Kager PA; Meenhorst PL
Neth J Med; 1995 Aug; 47(2):66-9. PubMed ID: 7566284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
